{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T06:09:32Z","timestamp":1792649372806,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/j.jaad.2016.03.001","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T08:45:58Z","timestamp":1463474758000},"page":"385-392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":147,"title":["Oral tranexamic acid (TA) in the treatment of melasma: A retrospective analysis"],"prefix":"10.1016","volume":"75","author":[{"given":"Hwee Chyen","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien Guan Steven","family":"Thng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chee Leok","family":"Goh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2016.03.001_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.det.2007.04.006","article-title":"Therapeutical approaches in melasma","volume":"25","author":"Prignano","year":"2007","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jaad.2016.03.001_bib2","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.jaad.2006.02.009","article-title":"The treatment of melasma: a review of clinical trials","volume":"55","author":"Gupta","year":"2006","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.03.001_bib3","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1001\/archderm.1995.01690240119022","article-title":"Melasma. Etiologic and therapeutic considerations","volume":"131","author":"Grimes","year":"1995","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2016.03.001_bib4","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jaad.2010.12.046","article-title":"Melasma: a comprehensive update: part I","volume":"65","author":"Sheth","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2016.03.001_bib5","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1468-3083.2009.03295.x","article-title":"A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma","volume":"23","author":"Ortonne","year":"2009","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2016.03.001_bib6","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1540-9740.2007.06338.x","article-title":"Melasma","volume":"6","author":"Scheinfeld","year":"2007","journal-title":"Skinmed"},{"key":"10.1016\/j.jaad.2016.03.001_bib7","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/ajd.12290","article-title":"Melasma: clinical diagnosis and management options","volume":"56","author":"Rodrigues","year":"2015","journal-title":"Australas J Dermatol"},{"key":"10.1016\/j.jaad.2016.03.001_bib8","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jdermsci.2007.01.009","article-title":"The vascular characteristics of melasma","volume":"46","author":"Kim","year":"2007","journal-title":"J Dermatol Sci"},{"key":"10.1016\/j.jaad.2016.03.001_bib9","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1001\/jama.1967.03120090043007","article-title":"Melasma induced by oral contraceptive drugs","volume":"199","author":"Resnik","year":"1967","journal-title":"JAMA"},{"key":"10.1016\/j.jaad.2016.03.001_bib10","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/jid.1962.136","article-title":"Melanogenesis in human skin following exposure to long ultraviolet and visible light","volume":"39","author":"Pathak","year":"1962","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jaad.2016.03.001_bib11","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/jidsymp.2008.7","article-title":"Latest insights into skin hyperpigmentation","volume":"13","author":"Ortonne","year":"2008","journal-title":"J Investig Dermatol Symp Proc"},{"key":"10.1016\/j.jaad.2016.03.001_bib12","first-page":"3129","article-title":"Treatment of melasma with tranexamic acid","volume":"13","author":"Nijor","year":"1979","journal-title":"Clin Res"},{"key":"10.1016\/j.jaad.2016.03.001_bib13","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1111\/j.1468-3083.2012.04464.x","article-title":"Effect of tranexamic acid on melasma: a clinical trial with histological evaluation","volume":"27","author":"Na","year":"2013","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2016.03.001_bib14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1248\/jhs.53.389","article-title":"Mechanism of the inhibitory effect of tranexamic acid on melanogenesis in cultured human melanocytes in the presence of keratinocyte-conditioned medium","volume":"53","author":"Maeda","year":"2007","journal-title":"J Health Sci"},{"key":"10.1016\/j.jaad.2016.03.001_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/jocd.12026","article-title":"Tranexamic acid: an important adjuvant in the treatment of melasma","volume":"12","author":"Tse","year":"2013","journal-title":"J Cosmet Dermatol"},{"key":"10.1016\/j.jaad.2016.03.001_bib16","doi-asserted-by":"crossref","first-page":"292","DOI":"10.3109\/09546634.2011.643220","article-title":"Role of oral tranexamic acid in melasma patients treated with IPL and low fluence QS Nd:YAG laser","volume":"24","author":"Cho","year":"2013","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2016.03.001_bib17","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s00266-012-9899-9","article-title":"Treatment of melasma with oral administration of tranexamic acid","volume":"36","author":"Wu","year":"2012","journal-title":"Aesthetic Plast Surg"},{"key":"10.1016\/j.jaad.2016.03.001_bib18","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1097\/00042728-200605000-00004","article-title":"Localized intradermal microinjection of tranexamic acid for treatment of melasma in Asian patients: a preliminary clinical trial","volume":"32","author":"Lee","year":"2006","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2016.03.001_bib19","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.thromres.2014.11.012","article-title":"Tranexamic acid\u2013an old drug still going strong and making a revival","volume":"135","author":"Tengborn","year":"2015","journal-title":"Thromb Res"},{"key":"10.1016\/j.jaad.2016.03.001_bib20","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2165\/11209070-000000000-00000","article-title":"Tranexamic acid: a review of its use in the treatment of hyperfibrinolysis","volume":"72","author":"McCormack","year":"2012","journal-title":"Drugs"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216014985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962216014985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:38:53Z","timestamp":1759271933000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962216014985"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8]]},"references-count":20,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S0190962216014985"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2016.03.001","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726378167.793521671","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2016,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral tranexamic acid (TA) in the treatment of melasma: A retrospective analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2016.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}